130 related articles for article (PubMed ID: 2816615)
21. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor].
Kuroda K; Ishii N; Fukasawa K; Shirai M; Tajima M; Matsushima M; Miura K; Takanami M; Matsuhashi M; Kuwabara T; Matsumoto H; Sugita M
Hinyokika Kiyo; 1998 Aug; 44(8):547-52. PubMed ID: 9783189
[TBL] [Abstract][Full Text] [Related]
22. [A clinical study of superficial bladder cancer with grade 3 components].
Iiyama T; Hariu K; Kawai M; Kamiyama Y; Okano Y; Shimizu H; Tomomasa H; Iizumi T; Yazaki T; Umeda T
Hinyokika Kiyo; 1998 Jun; 44(6):375-9. PubMed ID: 9719934
[TBL] [Abstract][Full Text] [Related]
23. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
24. [Radical cystectomy for superficial tumors in the BCG era].
Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
[TBL] [Abstract][Full Text] [Related]
25. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study.
Prout GR; Wesley MN; Yancik R; Ries LA; Havlik RJ; Edwards BK
Cancer; 2005 Oct; 104(8):1638-47. PubMed ID: 16130136
[TBL] [Abstract][Full Text] [Related]
26. High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
Pham HT; Soloway MS
Semin Urol Oncol; 1997 Aug; 15(3):147-53. PubMed ID: 9394909
[TBL] [Abstract][Full Text] [Related]
27. [A case of transitional cell carcinoma with squamous differentiation which developed squamous cell carcinoma in situ in the clinical course].
Sugiura S; Makiyama K; Yokomizo Y; Umemoto S; Miyoshi Y; Nakaigawa N; Ogawa T; Uemurai H; Yao M; Kubota Y; Yamanaka S
Hinyokika Kiyo; 2006 Sep; 52(9):715-8. PubMed ID: 17040058
[TBL] [Abstract][Full Text] [Related]
28. [Clinical studies of patients with bladder tumors].
Matsuura T; Sugiyama T; Tsujihashi H; Kato Y; Boku E; Kunikata S; Kanda H; Kataoka K; Nagai N; Kaneko S
Hinyokika Kiyo; 1983 Jan; 29(1):23-30. PubMed ID: 6203375
[TBL] [Abstract][Full Text] [Related]
29. [Total cystectomy for urinary bladder cancer: clinicopathological study of 95 cases].
Murase T; Takashi M; Aota Y; Shimoji T; Miyake K; Mitsuya H
Hinyokika Kiyo; 1985 Apr; 31(4):615-21. PubMed ID: 4036737
[TBL] [Abstract][Full Text] [Related]
30. Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma.
Li LY; Yang M; Zhang HB; Su XK; Xu WF; Chen Y; Shen ZJ; Gao X
BJU Int; 2008 Aug; 102(5):566-71. PubMed ID: 18410436
[TBL] [Abstract][Full Text] [Related]
31. Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer.
Akçetin Z; Todorov J; Tüzel E; Engehausen DG; Krause FS; Sauer R; Schrott KM; Rödel C
Anticancer Res; 2005; 25(3A):1623-8. PubMed ID: 16033071
[TBL] [Abstract][Full Text] [Related]
32. [A clinical study of recurrence and progression of grade 3 superficial bladder tumor].
Ikegami S; Tsuji A; Suzuki S; Sumitomo M; Kimura F; Asano T; Nakajima F; Hayakawa M
Hinyokika Kiyo; 1999 May; 45(5):325-9. PubMed ID: 10410314
[TBL] [Abstract][Full Text] [Related]
33. [Cystectomy in bladder cancer patients].
Galeev RKh
Vopr Onkol; 1992; 38(9):1118-24. PubMed ID: 1300828
[TBL] [Abstract][Full Text] [Related]
34. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
[TBL] [Abstract][Full Text] [Related]
35. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.
Malmström PU
Scand J Urol Nephrol Suppl; 1988; 112():1-55. PubMed ID: 3068792
[TBL] [Abstract][Full Text] [Related]
36. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
37. TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.
Serretta V; Pavone C; Ingargiola GB; Daricello G; Allegro R; Pavone-Macaluso M
Eur Urol; 2004 Jun; 45(6):730-5; discussion 735-6. PubMed ID: 15149744
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic factors of superficial bladder cancer recurring after initial transurethral resection].
Nakata S; Nakano K; Takahashi H; Shimizu K
Hinyokika Kiyo; 2005 Apr; 51(4):229-33. PubMed ID: 15912780
[TBL] [Abstract][Full Text] [Related]
39. The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy.
Cho KS; Seo JW; Park SY; Cho NH; Choi YD; Yang SC; Hong SJ
Urol Int; 2008; 81(4):394-8. PubMed ID: 19077398
[TBL] [Abstract][Full Text] [Related]
40. Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapy.
Saika T; Tsushima T; Nasu Y; Arata R; Kaku H; Kusaka N; Kumon H
Jpn J Clin Oncol; 2002 Nov; 32(11):461-5. PubMed ID: 12499418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
